Ischemic neurons recruit natural killer cells that accelerate brain infarction

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 7, 2014, Pages 2704-2709

  Gan, Yan ^a,b   Liu, Qiang ^a,b   Wu, Wei ^b   Yin, Jun Xiang ^b   Bai, Xue Feng ^c   Shen, Rulong ^c   Wang, Yongjun ^d   Chen, Jieli ^e   Cava, Antonio La ^f   Poursine Laurent, Jennifer ^g,h   Yokoyama, Wayne ^g,h   Shi, Fu Dong ^a,b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b BARROW NEUROLOGICAL INSTITUTE   (United States)

^c THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^d CAPITAL MEDICAL UNIVERSITY   (China)

^e HENRY FORD HOSPITAL   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g Southcoast Health   (United States)

^h WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Innate immunity; Ischemic stroke; Middle cerebral artery occlusion

Indexed keywords

CHEMOKINE RECEPTOR CX3CR1; FRACTALKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 1BETA; NATURAL KILLER CELL RECEPTOR NKG2A; NATURAL KILLER CELL RECEPTOR NKG2D; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN PERFUSION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE EXACERBATION; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; INFLAMMATION; INNATE IMMUNITY; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NATURAL KILLER CELL; NERVE CELL EXCITABILITY; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; SYNAPTIC TRANSMISSION; T LYMPHOCYTE;

INNATE IMMUNITY; ISCHEMIC STROKE; MIDDLE CEREBRAL ARTERY OCCLUSION;

ANIMALS; BRAIN; BRAIN INFARCTION; BRAIN ISCHEMIA; CHEMOKINE CX3CL1; DNA-BINDING PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; IMMUNITY, INNATE; KILLER CELLS, NATURAL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURONS; STROKE;

EID: 84894340282     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1315943111     Document Type: Article

References (33)

1. Eltzschig HK, Carmeliet P (2011) Hypoxia and inflammation. N Engl J Med 364(7): 656-665.
2. Iadecola C, Anrather J (2011) The immunology of stroke: From mechanisms to translation. Nat Med 17(7):796-808.
3. Eltzschig HK, Eckle T (2011) Ischemia and reperfusion-from mechanism to translation. Nat Med 17(11):1391-1401.
4. Hurn PD, et al. (2007) T-and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation. J Cereb Blood Flow Metab 27(11):1798-1805.
5. Kleinschnitz C, et al. (2010) Early detrimental T-cell effects in experimental cerebral ischemia are neither related to adaptive immunity nor thrombus formation. Blood 115(18):3835-3842.
6. Yilmaz G, Arumugam TV, Stokes KY, Granger DN (2006) Role of T lymphocytes and interferon-gamma in ischemic stroke. Circulation 113(17):2105-2112.
7. Liesz A, et al. (2009) Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat Med 15(2):192-199.
8. Shichita T, et al. (2009) Pivotal role of cerebral interleukin-17- producing gammadeltaT cells in the delayed phase of ischemic brain injury. Nat Med 15(8):946-950.
9. Shi FD, Ransohoff RM (2010) Natural killer cells in the central nervous system. Natural Killer Cells, eds Lotze MT, Thomson AW (Academic, Maryland Heights, MO), pp 373-383.
10. Walzer T, et al. (2007) Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46. Proc Natl Acad Sci USA 104(9):3384-3389.
11. Chen J, et al. (2005) Endothelial nitric oxide synthase regulates brain-derived neurotrophic factor expression and neurogenesis after stroke in mice. J Neurosci 25(9): 2366-2375.
12. Hackett J, Jr., et al. (1986) Origin and differentiation of natural killer cells. II. Functional and morphologic studies of purified NK-1.1+ cells. J Immunol 136(8): 3124-3131.
13. Campbell JJ, et al. (2001) Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J Immunol 166(11):6477-6482.
14. Imai T, et al. (1997) Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 91(4): 521-530.
15. Tarozzo G, Campanella M, Ghiani M, Bulfone A, Beltramo M (2002) Expression of fractalkine and its receptor, CX3CR1, in response to ischaemia-reperfusion brain injury in the rat. Eur J Neurosci 15(10):1663-1668.
16. Hao J, et al. (2010) Central nervous system (CNS)-resident natural killer cells suppress Th17 responses and CNS autoimmune pathology. J Exp Med 207(9):1907-1921.
17. Backström E, et al. (2003) Natural killer cell-mediated lysis of dorsal root ganglia neurons via RAE1/NKG2D interactions. Eur J Immunol 33(1):92-100.
18. Young JD, Hengartner H, Podack ER, Cohn ZA (1986) Purification and characterization of a cytolytic pore-forming protein from granules of cloned lymphocytes with natural killer activity. Cell 44(6):849-859.
19. Fan Y, et al. (2008) Transient cerebral ischemia increases CA1 pyramidal neuron excitability. Exp Neurol 212(2):415-421.
20. Backström E, Chambers BJ, Kristensson K, Ljunggren HG (2000) Direct NK cell-mediated lysis of syngenic dorsal root ganglia neurons in vitro. J Immunol 165(9): 4895-4900.
21. Shieh TM, et al. (2001) Functional analyses of natural killer cells in macaques infected with neurovirulent simian immunodeficiency virus. J Neurovirol 7(1):11-24.
22. Yenari MA, Han HS (2012) Neuroprotective mechanisms of hypothermia in brain ischaemia. Nat Rev Neurosci 13(4):267-278.
23. Wardman P (2007) Fluorescent and luminescent probes for measurement of oxidative and nitrosative species in cells and tissues: Progress, pitfalls, and prospects. Free Radic Biol Med 43(7):995-1022.
24. Shi FD, Ljunggren HG, La Cava A, Van Kaer L (2011) Organ-specific features of natural killer cells. Nat Rev Immunol 11(10):658-671.
25. Hao J, et al. (2011) Interleukin-2/interleukin-2 antibody therapy induces target organ natural killer cells that inhibit central nervous system inflammation. Ann Neurol 69(4): 721-734.
26. Jung S, et al. (2000) Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol Cell Biol 20(11): 4106-4114.
27. Gibson CL, Coomber B, Murphy SP (2011) Progesterone is neuroprotective following cerebral ischaemia in reproductively ageing female mice. Brain 134(Pt 7):2125-2133.
28. Pineau I, Lacroix S (2007) Proinflammatory cytokine synthesis in the injured mouse spinal cord: Multiphasic expression pattern and identification of the cell types involved. J Comp Neurol 500(2):267-285.
29. Cardona AE, et al. (2006) Control of microglial neurotoxicity by the fractalkine receptor. Nat Neurosci 9(7):917-924.
30. Shi FD, et al. (2000) Natural killer cells determine the outcome of B cell-mediated autoimmunity. Nat Immunol 1(3):245-251.
31. Desai NS, Rutherford LC, Turrigiano GG (1999) Plasticity in the intrinsic excitability of cortical pyramidal neurons. Nat Neurosci 2(6):515-520.
32. Karmarkar UR, Buonomano DV (2006) Different forms of homeostatic plasticity are engaged with distinct temporal profiles. Eur J Neurosci 23(6):1575-1584.
33. Hao J, et al. (2011) Attenuation of CNS inflammatory responses by nicotine involves a7 and non-a7 nicotinic receptors. Exp Neurol 227(1):110-119.